The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group

  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
    1. About this group
    2. Reviews
      1. Abdominal drainage versus no drainage post gastrectomy for gastric cancerReview
      2. Acupuncture for functional dyspepsiaReview
      3. Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthroughReview
      4. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitisReview
      5. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescentsReview
      6. Antioxidants for pain in chronic pancreatitisReview
      7. Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleedingReview
      8. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disordersReview
      9. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancerReview
      10. Chemotherapy for advanced gastric cancerReview
      11. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junctionReview
      12. Chinese herbal medicines for acute pancreatitisReview
      13. Chinese herbal medicines for esophageal cancerReview
      14. Chinese herbal medicines for induction of remission in advanced or late gastric cancerReview
      15. Cisapride treatment for gastro-oesophageal reflux in childrenReview
      16. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagusReviewWithdrawn
      17. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleedingReview
      18. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancerReviewDiagnostic
      19. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerReviewDiagnostic
      20. Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitisReview
      21. Early versus delayed laparoscopic cholecystectomy for acute gallstone pancreatitisReview
      22. Endoscopic mucosal resection for early gastric cancerReview
      23. Endoscopic or surgical intervention for painful obstructive chronic pancreatitisReviewNew Search
      24. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasiaReview
      25. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitisReviewWithdrawn
      26. Enteral nutrition formulations for acute pancreatitisReviewNew
      27. Enteral versus parenteral nutrition for acute pancreatitisReview
      28. Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcersReview
      29. Eradication of Helicobacter pylori for non-ulcer dyspepsiaReviewWithdrawn
      30. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patientsReview
      31. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomachReview
      32. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisReview
      33. Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcerReview
      34. Initial management strategies for dyspepsiaReview
      35. Interventions for dysphagia in oesophageal cancerReview
      36. Laparoscopic repair for perforated peptic ulcer diseaseReview
      37. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesionsReview
      38. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseReviewWithdrawn
      39. Medical treatments in the short term management of reflux oesophagitisReviewWithdrawn
      40. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adultsReview
      41. Metoclopramide for post-pyloric placement of naso-enteral feeding tubesReview
      42. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two yearsReview
      43. Neoadjuvant chemotherapy versus none for resectable gastric cancerReviewWithdrawn
      44. Nitrates for achalasiaReview
      45. Non-surgical interventions for eosinophilic esophagitisReview
      46. Omentoplasty for oesophagogastrostomy after oesophagectomyReview
      47. Opioids for acute pancreatitis painReview
      48. Optimum duration of regimens for Helicobacter pylori eradicationReview
      49. Palliative biliary stents for obstructing pancreatic carcinomaReview
      50. Pancreatic enzymes for chronic pancreatitisReview
      51. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbancesReview
      52. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusReview
      53. Pharmacological interventions for non-ulcer dyspepsiaReviewWithdrawn
      54. Pharmacological treatment of children with gastro-oesophageal refluxReview
      55. Post-surgical chemotherapy versus surgery alone for resectable gastric cancerReview
      56. Preoperative chemotherapy for resectable thoracic esophageal cancerReview
      57. Preoperative radiotherapy for esophageal carcinomaReview
      58. Prevention of NSAID-induced gastroduodenal ulcersReview
      59. Prophylactic gastrojejunostomy for unresectable periampullary carcinomaReview
      60. Proton pump inhibitor treatment for acute peptic ulcer bleedingReview
      61. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingReview
      62. Psychological interventions for non-ulcer dyspepsiaReviewWithdrawn
      63. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinomaReview
      64. Red cell transfusion for the management of upper gastrointestinal haemorrhageReview
      65. Resection versus other treatments for locally advanced pancreatic cancerReview
      66. Screening for oesophageal cancerReview
      67. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseReview
      68. Somatostatin analogues for pancreatic surgeryReview
      69. Stents for the prevention of pancreatic fistula following pancreaticoduodenectomyReview
      70. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagusReview
      71. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancerReview
      72. Tranexamic acid for upper gastrointestinal bleedingReview
      73. Treatment for Barrett's oesophagusReview
    3. Protocols
      1. Adjuvant therapy for resected pancreatic cancerProtocol
      2. Antacids and lifestyle advice for reflux oesophagitis and Endoscopy Negative Reflux DiseaseProtocol
      3. Antidepressants and anxiolytics for functional dyspepsiaProtocol
      4. Antioxidants for acute pancreatitisProtocol
      5. Antiproteases for acute pancreatitisProtocol
      6. Biodegradable anastomotic ring for gastrointestinal anastomosisProtocol
      7. Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in childrenProtocolDiagnostic
      8. Carbon dioxide detection for testing nasogastric tube placement in adultsProtocolDiagnostic
      9. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancerProtocol
      10. Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancerProtocol
      11. Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesionsProtocol
      12. Chinese herbal medicine for advanced pancreatic cancerProtocol
      13. Conservative interventions for the management of impacted food bolus in the oesophagusProtocol
      14. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerProtocolDiagnostic
      15. Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitisProtocol
      16. Electrosurgical current for endoscopic biliary sphincterotomy (EBS) for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocol
      17. Endoscopic drainage with or without endo-ultrasonography for pancreatic pseudocystProtocol
      18. Endoscopic intervention for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocolWithdrawn
      19. Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgeryProtocol
      20. Eradication of Helicobacter pylori for iron deficiencyProtocol
      21. Erlotinib for advanced pancreatic cancerProtocol
      22. Extended lymph node resection versus standard resection for pancreatic and peri-ampullary adenocarcinomaProtocol
      23. Fasting for haemostasis in children with gastrointestinal bleedingProtocol
      24. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgeryProtocol
      25. Helicobacter pylori eradication for premalignant lesions of the gastric mucosaProtocol
      26. Helicobacter pylori eradication for the prevention of gastric neoplasiaProtocol
      27. High dose versus standard dose proton pump inhibitor for short term management of erosive reflux oesophagitisProtocol
      28. Imaging modalities for characterising focal pancreatic lesionsProtocolDiagnostic
      29. Imatinib mesylate for gastrointestinal stromal tumours (GISTs)ProtocolWithdrawn
      30. Interventions for necrotising pancreatitisProtocol
      31. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care unitsProtocol
      32. Intraperitoneal chemotherapy for gastric carcinomaProtocol
      33. Laparoscopic cardiomyotomy versus endoscopic pneumatic dilation for primary achalasiaProtocol
      34. Laparoscopic fundoplication for gastro-oesophageal reflux disease (GORD) in adultsProtocol
      35. Laparoscopic versus open distal pancreatectomy for pancreatic cancerProtocol
      36. Laparoscopic versus open gastrectomy for gastric cancerProtocol
      37. Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancerProtocol
      38. Lexipafant for acute pancreatitisProtocol
      39. Management strategies for pancreatic pseudocysts: a network meta-analysisProtocol
      40. Medical versus surgical treatment for refractory or recurrent peptic ulcerProtocol
      41. Mesh reinforcement versus primary repair in laparoscopic paraoesophageal hernia repairs of the hiatusProtocol
      42. Minimal access drainage procedures for patients with necrotising pancreatitisProtocol
      43. Molecular-targeted therapy for advanced gastric cancerProtocol
      44. Nasogastric versus nasojejunal tube feeding for severe acute pancreatitisProtocol
      45. Nonsteroidal anti-inflammatories (NSAIDs) and aspirin for intestinal metaplasia of the stomachProtocol
      46. Optimum antibiotic doses for Helicobacter pylori eradicationProtocol
      47. Optimum second-line regimens for Helicobacter pylori eradicationProtocol
      48. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP)Protocol
      49. Percutaneous endoscopic gastrostomy versus radiologically placed gastrostomies for swallowing disturbancesProtocol
      50. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infectionProtocol
      51. Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancerProtocol
      52. Pharmacological interventions for acute pancreatitis: a network meta-analysisProtocol
      53. Postoperative chemotherapy or radiotherapy for esophageal cancerProtocol
      54. Pregabalin for decreasing pancreatic pain in chronic pancreatitisProtocol
      55. Preoperative radiotherapy chemotherapy and surgery versus surgery alone for esophageal cancerProtocol
      56. Probiotics as adjunctive therapy for eradication of Helicobacter pylori infectionProtocol
      57. Prokinetics for functional dyspepsiaProtocol
      58. Prophylactic abdominal drainage for pancreatic surgeryProtocol
      59. Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradicationProtocol
      60. Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux diseaseProtocol
      61. Proton pump inhibitors for functional dyspepsiaProtocol
      62. Routine cholecystectomy during Roux-en-Y gastric bypass with or without choledocholithiasisProtocol
      63. Sequential versus standard triple therapy for Helicobacter pylori eradicationProtocol
      64. Somatostatin analogues for carcinoid syndromeProtocol
      65. Somatostatin or somatostatin analogues for acute non-variceal upper gastrointestinal bleedingProtocol
      66. Stapler versus scalpel resection followed by hand-sewn closure of the pancreatic remnant for distal pancreatectomyProtocol
      67. Surgical versus non-surgical treatment for oesophageal cancerProtocol
  53. Cochrane Wounds Group